[Federal Register Volume 75, Number 223 (Friday, November 19, 2010)]
[Notices]
[Page 70915]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-29206]



[[Page 70915]]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Intent To Grant an Exclusive License for a U.S. Government-Owned 
Invention

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 35 U.S.C. 209(e), and 37 CFR 404.7 
(a)(1)(i) and 37 CFR 404.7 (b)(1)(i), announcement is made of the 
intent to grant an exclusive, revocable license for the invention 
claimed in the patent application PCT/US2009/045818, filed June 1, 
2009, entitled, ``Meningococcal Multivalent Native Outer Membrane 
Vesicle Vaccine, Methods of Making and Use Thereof,'' to Merck Sharp & 
Dohme Corp., with its principal place of business at One Merck Drive, 
Whitehouse Station, NJ 08889-3400.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For licensing issues, Dr. Paul Mele, 
Office of Research and Technology Applications (ORTA), (301) 619-6664. 
For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-
7808, both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: Anyone wishing to object to the grant of 
this license can file written objections along with supporting 
evidence, if any, within 15 days from the date of this publication. 
Written objections are to be filed with the Command Judge Advocate (see 
ADDRESSES).

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2010-29206 Filed 11-18-10; 8:45 am]
BILLING CODE 3710-08-P